Yeshwanth Vedire, MD, Robert Seager, PhD, Erik Van Roey, PhD, Shuang Gao, PhD, Mary Nesline, PhD, Jeffrey Conroy, PhD, Grace Dy, MD, Joseph Barbi, PhD, Sarabjot Pabla, PhD, and Sai Yendamuri, MD
The Labcorp Oncology Medical Affairs team presented groundbreaking research during the American Society of Clinical Oncology (ASCO) annual meeting held June 2-6 in Chicago, Illinois.
Today Labcorp announce a strategic collaboration with Resilience to accelerate the development of cell and gene therapies (CGT). By leveraging the breadth of Labcorp’s enterprise-wide CGT solutions with the leading CGT manufacturing science and technologies from Resilience, w
COLUMBUS, Ohio--(BUSINESS WIRE)--Forge Biologics, a leading manufacturer of genetic medicines, today announced a gene therapy development and manufacturing collaboration with Labcorp (NYSE: LH), a leading global life sciences company.
Joel R. Eisner (1), Greg M. Mayhew (1), James M. Davison (1), Kirk D. Beebe (1), Yoichiro Shibata (1), Yuelong Guo1 (3), Carol Farhangfar (2), Farhang Farhangfar (2) , Josh M. Uronis (1), Jeffrey M. Conroy (3), Michael V. Milburn (1), David Neil Hayes (4), Kathryn F. Mileham (2), 1 GeneCentric Therapeutics, Inc. 2 Levine Cancer Institute, Atrium Health 3 OmniSeq, now part of Labcorp, Buffalo, NY 4 University of Tennessee Health Science Center, Center for Cancer Research.
